ESR1 and ductal breast carcinoma in situ: Analysis of a core needle biopsy of this mass led to a diagnosis of ductal carcinoma in situ (DCIS), nuclear grade (NG) = 2, which was negative for the expression of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal receptor 2 (HER2).